ARCA biopharma, Inc.
METHODS AND COMPOSITIONS INVOLVING BUCINDOLOL FOR THE TREATMENT OF ATRIAL FIBRILLATION

Last updated:

Abstract:

The current methods and compositions relate to treatment of atrial fibrillation with bucindolol in patients, including patientswith heart failure, after being determined to be homozygous Arg389 in the .beta..sub.1 adrenergic receptor gene.

Status:
Application
Type:

Utility

Filling date:

5 May 2020

Issue date:

27 Aug 2020